You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review

Article info

Article menu
Oncology
Protocol
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review

Authors

  • Madelé van Dyk Flinders Health and Medical Research Institute - Cancer, Flinders University, Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  • Chelsea Boylan Flinders Health and Medical Research Institute - Cancer, Flinders University College of Medicine and Public Health, Bedford Park, South Australia, Australia PubMed articlesGoogle scholar articles
  • Robin Michelet Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, GermanyPharMetrX Graduate Research Training Program, Postdam/Berlin, UK PubMed articlesGoogle scholar articles
  • Anna M Mc Laughlin Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, GermanyPostdam/Berlin, PharMetrX Graduate Research Training Program, Postdam/Berlin, Germany PubMed articlesGoogle scholar articles
  • Ganessan Kichenadasse Flinders Health and Medical Research Institute - Cancer, Flinders University College of Medicine and Public Health, Bedford Park, South Australia, AustraliaMedical Oncology, Flinders Medical Centre, Bedford Park, South Australia, Australia PubMed articlesGoogle scholar articles
  • Nikki May SA Health Library Service, Bedford Park, South Australia, Australia PubMed articlesGoogle scholar articles
  • Victoria Ziesenitz Pediatric Cardiology & Congenital Heart Diseases, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Johannes N Van Den Anker Division of Paediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel, Basel, SwitzerlandDivision of Clinical Pharmacology, Children's National Hospital, Washington, District of Columbia, USA PubMed articlesGoogle scholar articles
  • Stefanie L Groenland Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Noord-Holland, The NetherlandsDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Alwin D R Huitema Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Noord-Holland, The NetherlandsDepartment of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Neeltje Steeghs Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Noord-Holland, The NetherlandsDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Gerd Mikus Clinical Pharmacology and Pharmacoepidemiology, UniversitatsKlinikum Heidelberg, Heidelberg, Baden-Württemberg, GermanyDepartment of Clinical Pharmacy and Biochemistry, Free University of Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Charlotte Kloft Freie Universitat Berlin Institut fur Pharmazie, Berlin, Germany PubMed articlesGoogle scholar articles
  • Heather Tapp Haematology/Oncology Unit, Women's and Children's Hospital Adelaide, North Adelaide, South Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Madelé van Dyk; madele.vandyk{at}flinders.edu.au
View Full Text

Citation

van Dyk M, Boylan C, Michelet R, et al
Plasma concentration guided dosing of drugs used for the treatment of childhood leukaemias: protocol for a systematic review
BMJ Open 2022;12:e053308. doi: 10.1136/bmjopen-2021-053308

Publication history

  • Received May 10, 2021
  • Accepted November 19, 2021
  • First published January 3, 2022.
Online issue publication 
January 03, 2022
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.